600976 Jianmin Pharmaceutical Group
- 44.62
- +1.66+3.86%
About Jianmin Pharmaceutical Group Company
The company was founded in the 10th year of Ming Chongzhen (1637). Formerly known as “Ye Kaitai”, it enjoyed the reputation of “Three Masters of the Early Qing Dynasty” and “China's Big Four Pharmaceutical Names” before liberation. In 1953, Ye Kaitai Pharmaceutical was partially transformed into “Wuhan Jianmin Pharmaceutical Factory” and listed on the Shanghai Stock Exchange in 2004. The company is mainly engaged in pharmaceutical R&D, manufacturing, wholesale and retail business, and is mainly divided into two major sectors: pharmaceutical industry and pharmaceutical business. Main products: Longmuzhuang bone granules, spleen and blood granules, Xiaojin capsules, bowel relief capsules, Jianmin throat tablets, estradiol gel. The company's honors include China's time-honored brand, the 45th most advanced unit in the top 100 Chinese pharmaceutical industry in 2002, the 2002 Quality Wanli Advanced Unit, the 2024 Health Industry Star Partner Award, the 2023 Top 50 Pharmaceutical Companies, the West Lake Award · Top 10 Pharmaceutical Manufacturing Digital Model Companies, and the 2024 Wuzhen Health Conference · VIP Strategic Cooperation Enterprise.
Company Profile
Company Executives
- Name
- Position
- Salary
- qin he
- Chairman, Directors, Strategy Development and Risk Control Committee Convener, Member of the Remuneration and Assessment Committee
- 2.10M
- siyang wang
- Acting Chairman, Directors, Member of the Strategy Development and Risk Control Committee, Nomination Committee Members, Acting Chairman of the Strategy Development and Risk Control Committee, Member of the Remuneration and Assessment Committee
- 60.00K
- jun wang
- Directors, President, Member of the Strategy Development and Risk Control Committee
- 891.40K
- zhenbo hu
- Directors, VP, Nomination Committee Members, Member of the Strategy Development and Risk Control Committee
- 210.40K
- rong pei
- Directors, Audit Committee Member
- 60.00K
- liang xu
- Directors, Audit Committee Member
- 60.00K
- shuqu li
- Independent Directors, Audit Committee Convener, Member of the Remuneration and Assessment Committee
- 90.00K
- zhi yang
- Independent Directors, Nomination Committee Members, Remuneration and Assessment Committee Convener, Audit Committee Member
- 90.00K
- yunpei guo
- Independent Directors, Member of the Remuneration and Assessment Committee, Nomination Committee Convener, Member of the Strategy Development and Risk Control Committee
- 90.00K
- jie zhou
- Board Secretary
- 408.80K
- hong cao
- Securities Affairs Representative
- --
- qijing xiao
- Chairman of the Supervisory Board, Auditors
- 18.00K
- jinqiu tang
- Auditors
- 502.20K
- jian hu
- Auditors
- 18.00K
- xuejun pei
- VP
- 540.00K
- zhijun huang
- VP
- 540.00K
- chaoyang cheng
- Chief Financial Officer (Head of Finance)
- 511.20K
- li chen
- Employee Supervisors
- 293.40K
- fangjing huang
- Employee Supervisors
- 300.60K
Analysis
Price Target
No Data
No Data